NCT02631746 2025-03-14Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/LymphomaNational Cancer Institute (NCI)Phase 2 Completed3 enrolled 8 charts
NCT00001941 2012-08-20Anti-Tac for Treatment of LeukemiaNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed34 enrolled 12 charts